Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Parkinson's disease does not always lead to dementia, but it does raise the risk considerably: roughly 25 to 30 percent of people with Parkinson's have dementia at any given time, and long-term studies suggest up to 50 to 80 percent may develop it if they live many years with the condition. Timing varies widely, though cognitive changes typically appear at least a year after movement symptoms begin and often 10 or more years after diagnosis, which is what distinguishes Parkinson's disease dementia from Lewy body dementia. Risk is higher with older age, more severe motor symptoms, hallucinations, and existing mild cognitive impairment, while early memory slips can also stem from medications, depression, sleep problems, or other treatable causes. There are several important factors and warning signs to weigh, so see below to understand more before drawing conclusions about your own situation.
If you or someone you love is noticing tremors, slowed movement, memory lapses, or confusion, guessing at the cause only delays answers that could change treatment; a free, instant, online symptom check takes just a few minutes, helps you sort which symptoms matter most, and gives you clear, organized information to bring to a doctor so your next appointment moves you forward instead of starting from scratch.
Last reviewed for medical accuracy: 09/29/2026
Parkinson’s disease (PD) is best known for its effects on movement—tremors, stiffness, and slowed motion. But many people with PD wonder: does Parkinson’s cause dementia? Cognitive changes can occur as the disease progresses. Understanding the likelihood, timing, and risk factors can help you plan, get support, and talk with your medical team.
While not everyone with PD develops dementia, a significant number do. When cognitive decline becomes severe enough to interfere with daily life—beyond what can be explained by physical slowing—it is called Parkinson’s disease dementia (PDD). Key points:
Estimates vary by study, but large-scale research gives us a clear picture:
These figures come from follow‐up studies of several hundred to thousands of people, and reflect an average risk. Individual chances depend on various factors.
The timing of cognitive decline varies widely:
Risk factors that can speed up the timeline include:
Keeping an eye on cognitive health can help you and your care team spot problems early. Common early signs include:
If you notice these changes in yourself or a loved one, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Several factors increase the likelihood or speed of dementia onset in Parkinson’s disease:
Understanding differences can guide expectations:
| Feature | Parkinson’s Disease Dementia | Alzheimer’s Disease |
|---|---|---|
| Onset timing | After motor symptoms (usually ≥1 year) | Primarily cognitive |
| Early symptoms | Executive dysfunction, visuospatial issues | Episodic memory loss |
| Hallucinations | Common | Less common until late stages |
| Response to medication | May worsen cognition (e.g., anticholinergics) | Some benefit from cholinesterase inhibitors |
While no treatment prevents PDD, certain strategies can support brain health:
Regular check‐ins with your neurologist or primary care doctor can track changes and adjust care plans.
Any sudden or severe cognitive change—such as new confusion, disorientation, or marked memory loss—warrants prompt medical attention. Likewise, signs of depression, hallucinations, or falls should trigger an evaluation. Always:
If you’re concerned, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to better understand your symptoms before your appointment.
Dementia in PD affects not only the person with the disease but also their support network. Helpful resources include:
Your health journey is unique. If you or a loved one are facing new or worsening cognitive symptoms, it’s important to speak to a doctor to explore diagnosis, treatment, and support options. While the idea of dementia can be worrying, early recognition and proactive care can make a meaningful difference in quality of life.
(References)
* Wada K, Nakashima K. [Mild cognitive impairment in Parkinson's disease]. Brain Nerve. 2012 Dec;64(12):1365-75. PMID: 23209063.
* Tokutake T, Ishikawa A, Yoshimura N, Miyashita A, Kuwano R, Nishizawa M, Ikeuchi T. Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation. Parkinsonism Relat Disord. 2014 Feb;20(2):262-4. doi: 10.1016/j.parkreldis.2013.11.008. Epub 2013 Nov 20. PMID: 24315198.
* Gu Y, Chen J, Lu Y, Pan S. Integrative Frequency Power of EEG Correlates with Progression of Mild Cognitive Impairment to Dementia in Parkinson's Disease. Clin EEG Neurosci. 2016 Apr;47(2):113-7. doi: 10.1177/1550059414543796. Epub 2014 Dec 16. PMID: 25519446.
* Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disord. 2016 Jun;31(6):861-81. doi: 10.1002/mds.26662. Epub 2016 May 19. PMID: 27193487.
* Aarsland D, Rajkumar AP, Hye A. Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):808. doi: 10.1136/jnnp-2017-315821. Epub 2017 Jun 12. PMID: 28607120.
* Weil RS, Costantini AA, Schrag AE. Mild Cognitive Impairment in Parkinson's Disease-What Is It? Curr Neurol Neurosci Rep. 2018 Mar 10;18(4):17. doi: 10.1007/s11910-018-0823-9. Epub 2018 Mar 10. PMID: 29525906; PMCID: PMC5845587.
* Mahmoudi Asl A, Mehdizadeh M, Raeesi Roudbari P, Mehdizadeh H, Habibi SA, Niazi Khatoon J, Taghizadeh G. Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System. Disabil Rehabil. 2022 Jan;44(1):44-51. doi: 10.1080/09638288.2020.1755728. Epub 2020 May 6. PMID: 32374182.
* Neri M, Braccia A, Panteghini C, Garavaglia B, Gualandi F, Cavallo MA, Scerrati A, Ferlini A, Sensi M. Parkinson's disease-dementia in trans LRP10 and GBA variants: Response to deep brain stimulation. Parkinsonism Relat Disord. 2021 Nov;92:72-75. doi: 10.1016/j.parkreldis.2021.10.020. Epub 2021 Oct 24. PMID: 34710740.
* Park M, Kwon J, Sohn YH, Lee PH, Baik K, Kang SY. Language impairment as a risk factor for dementia conversion in parkinson's disease with mild cognitive impairment: a quantitative EEG study. J Neural Transm (Vienna). 2026 Apr;133(4):607-617. doi: 10.1007/s00702-026-03103-5. Epub 2026 Feb 28. PMID: 41762437.
* Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, Iaccarino L, Collins EC, Hodsdon ME, Irwin D, Spindler M, Deik A, Dahodwala N, Cousins KAQ, Wolk DA, Shaw L, Weintraub D, Lee EB, Chen-Plotkin A, Mintun M, Siderowf A. Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease. Ann Neurol. 2026 Jun;99(6):1428-1437. doi: 10.1002/ana.78201. Epub 2026 Mar 18. PMID: 41848292; PMCID: PMC13206273.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.